Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control
Status:
Withdrawn
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Type II Diabetes Mellitus patients having surgery who adhere to their regular scheduled
metformin dosing and take this medication on the morning of surgery will have better glycemic
control peri-operatively and potentially suffer less morbidity compared to individuals taking
a placebo.